As of May 2, 2025, Pfizer's stock price stands at $23.93, which is a slight decrease from the previous day's close of $23.79. The trading volume for the day is 46,891,740 shares, which is significantly lower than the average volume of 98,540,187 shares observed on April 29, 2025.

Looking at the historical data, Pfizer's stock has been trending upward since April 2024, with each new low being higher than the previous one. This indicates a sustainable bullish trend with possible corrections as new resistance levels are reached. The long-term outlook for Pfizer stock looks positive, with potential for continued growth within the ascending channel.

Recently, there have been no major announcements from Pfizer that would significantly impact the stock price. However, the company's continued development of its vaccine to help prevent COVID-19 and its investigational protease inhibitor have been ongoing, which could potentially influence investor sentiment in the future.

Major analysts have been positive about Pfizer's stock, anticipating sustained growth throughout 2025. PandaForecast, for instance, projects that the stock will stabilize in January after fluctuating, ranging from $26.46 to $29.28. February and March are expected to see a significant increase, with highs above $30, finally reaching around $32.94. The trend is expected to continue, with price ranges in 2025 projected to be between $26.46 and $40.15.

In summary, while the current stock price is slightly lower than the previous day, the overall trend for Pfizer's stock remains positive. The lower trading volume on May 2, 2025, could be a temporary correction within the ascending channel. With ongoing developments in vaccine and protease inhibitor research, combined with positive analyst forecasts, Pfizer's stock is expected to continue its upward trajectory in the coming months.

For more http://www.quietplease.ai

Stock up on these deals
https://amzn.to/3QFpYIX

This content was created in partnership and with the help of Artificial Intelligence AI